Home / Olopatadine / Canada
CA ATC S01GX09 · updated 2 Nov 2026
Olopatadine shortage in Canada
Is there an Olopatadine shortage in Canada?
Yes. As of 2 Nov 2026, 5 Olopatadine products are reported short in Canada, the first since 1 Sep 2018. No return date has been given. Main reason: manufacturing problem.
Also short in Japan. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | ACT OLOPATADINE 0.1% (1) | ACTAVIS PHARMA COMPANY | 1 Sep 2018 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | ACT OLOPATADINE 0.2% (1) | ACTAVIS PHARMA COMPANY | 1 Sep 2018 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-OLOPATADINE (5 ML) | APOTEX INC | 1 Jun 2020 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-OLOPATADINE (2.5 ML) | APOTEX INC | 26 Mar 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP-OLOPATADINE (5 mL) | JAMP PHARMA CORPORATION | 7 Aug 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.